QUALITATIVE AND QUANTITATIVE COMPOSITION
1 vial MERIONAL 75 IU / MERIONAL 150 IU contains:
Active substance:
Urofolitropin (Urofollitropin) (follicle stimulating hormone FSH) - 75 IU / 150 IU
Luteinizing hormone (LH) (Luteinizing hormone) - 75 IU / 150 IU
LH activity can be increased by adding a Human chorionic gonadotropin (hCG).
PHARMACEUTICAL FORM
Powder and solvent for solution for injection
Of the powder: white lyophilised powder
Type of vehicle: colorless transparent solution
INDICATION
1 Anovulation (including polycystic ovarian disease, PCOD) in women who do not respond to treatment with clomifene citrate.
2 Stimulating multiple follicular development in patients who will undergo assisted reproductive technologies (ART) such as fertilization in-vitro (IVF), gamete intra-fallopian transplantation (GIFT) and zygote intra-fallopian transplantation (ZIFT).
3. MERIONAL is indicated for the stimulation of spermatogenesis in men with congenital or acquired hypogonadotropic hypogonadism and concomitant treatment with human chorionic gonadotropin.